385 related articles for article (PubMed ID: 9776713)
1. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
2. Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain.
Schloot NC; Willemen S; Duinkerken G; de Vries RR; Roep BO
J Autoimmun; 1998 Apr; 11(2):169-75. PubMed ID: 9650096
[TBL] [Abstract][Full Text] [Related]
3. Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis.
Li R; Li X; Li Z
Clin Immunol; 2006; 118(2-3):317-23. PubMed ID: 16343992
[TBL] [Abstract][Full Text] [Related]
4. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
[TBL] [Abstract][Full Text] [Related]
5. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects.
Schloot NC; Roep BO; Wegmann DR; Yu L; Wang TB; Eisenbarth GS
Diabetologia; 1997 Mar; 40(3):332-8. PubMed ID: 9084973
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
Ding L; Shevach EM
J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99).
Vergelli M; Hemmer B; Utz U; Vogt A; Kalbus M; Tranquill L; Conlon P; Ling N; Steinman L; McFarland HF; Martin R
Eur J Immunol; 1996 Nov; 26(11):2624-34. PubMed ID: 8921948
[TBL] [Abstract][Full Text] [Related]
8. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
[TBL] [Abstract][Full Text] [Related]
9. T cell activation and anergy to islet cell antigen in type I diabetes.
Miyazaki I; Cheung RK; Gaedigk R; Hui MF; Van der Meulen J; Rajotte RV; Dosch HM
J Immunol; 1995 Feb; 154(3):1461-9. PubMed ID: 7822811
[TBL] [Abstract][Full Text] [Related]
10. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation.
Chen YZ; Matsushita S; Nishimura Y
J Immunol; 1996 Nov; 157(9):3783-90. PubMed ID: 8892606
[TBL] [Abstract][Full Text] [Related]
11. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence.
Schountz T; Kasselman JP; Ford SR; Murray JS
Cell Immunol; 1996 Mar; 168(2):193-200. PubMed ID: 8640865
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
Li X; Li R; Li Z
Tissue Antigens; 2006 Jan; 67(1):45-52. PubMed ID: 16451200
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a human T cell line reactive to a 52 kDa islet protein.
Sobel DO; Fleisher T; Karounos DG
J Autoimmun; 1997 Aug; 10(4):387-94. PubMed ID: 9237802
[TBL] [Abstract][Full Text] [Related]
15. Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity.
Anderton SM; Manickasingham SP; Burkhart C; Luckcuck TA; Holland SJ; Lamont AG; Wraith DC
J Immunol; 1998 Oct; 161(7):3357-64. PubMed ID: 9759852
[TBL] [Abstract][Full Text] [Related]
16. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus.
Roep BO; Duinkerken G; Schreuder GM; Kolb H; de Vries RR; Martin S
Eur J Immunol; 1996 Jun; 26(6):1285-9. PubMed ID: 8647206
[TBL] [Abstract][Full Text] [Related]
17. T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects.
Semana G; Gausling R; Jackson RA; Hafler DA
J Autoimmun; 1999 Jun; 12(4):259-67. PubMed ID: 10330297
[TBL] [Abstract][Full Text] [Related]
18. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
[TBL] [Abstract][Full Text] [Related]
19. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes.
Lohmann T; Leslie RD; Londei M
J Autoimmun; 1996 Jun; 9(3):385-9. PubMed ID: 8816975
[TBL] [Abstract][Full Text] [Related]
20. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
